html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Heidelberg Pharma AG
/ Key words: Conference
br/
Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP101 to be Presented at International Myeloma Society Annual...
Lire...
28/08/2025 03:50
EQS-Adhoc: Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pEQSAdhoc: Heidelberg Pharma AG / Key words: Financingbr/
Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250CDx br/br/
28Aug2025 / 03:50...
Lire...
10/07/2025 07:03
EQS-News: Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Heidelberg Pharma AG
/ Key words: Half Year Report
br/
Heidelberg Pharma Reports on First HalfYear 2025 and the Positive Course of Business br/br/
10.07.2025 / 07:03...
Lire...
27/05/2025 08:07
EQS-News: Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Heidelberg Pharma AG
/ Key words: Study
br/
Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitinbased ADC Candidate HDP102 for NonHodgkin Lymphoma...
Lire...
15/05/2025 14:31
EQS-News: Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Heidelberg Pharma AG
/ Key words: AGM/EGM
br/
Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board...
Lire...
14/05/2025 18:40
EQS-News: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Heidelberg Pharma AG
/ Key words: Conference
br/
Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP101 at EHA 2025 br/br/
14.05.2025...
Lire...
24/04/2025 07:16
EQS-News: Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Heidelberg Pharma AG
/ Key words: Quarterly / Interim Statement
br/
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025...
Lire...
26/03/2025 09:23
EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Heidelberg Pharma AG
/ Key words: Conference
br/
Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 br/br/
26.03.2025 / 09:23...
Lire...
21/03/2025 07:07
EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Heidelberg Pharma AG
/ Key words: Annual Report
br/
Heidelberg Pharma announces financial figures and reports on successful business performance in 2024 br/br/
21.03.2025...
Lire...